By Harry Holmes2025-07-31T07:03:00
The group is performing better in emerging markets which make up around a third of its revenue
Sensodyne-maker Haleon has cut its growth forecast for the year due to weaker sales in the US
Already have an account? Sign in here
Already have an account? Sign in here